Benzinga's Top Analyst Calls From April 5, 2018

These headlines first appeared on Benzinga Pro.

DA Davidson says Cadence Design Systems Inc CDNS’s business strength is not reflected in its weak stock performance, upgrades from Neutral to Buy.
Buckingham Research initiates coverage on Houlihan Lokey Inc HLI with Buy rating and $54 price target, implying 20 percent upside. Says co.’s “highly diversified franchise across capital-light advisory businesses and unique focus on the middle-market” reduce volatility and limit competitive risks.
Evercore out positive on Heron Therapeutics Inc HRTX, gives bullish scenario of $150/share If HTX-011 is rapidly adopted by hospital pharmacies & committees, as able to expand into low vol. Procedures, and is able to reduce hospitalization duration post-procedures.
Bank of America raises price target on Boston Scientific Corporation BSX from $30 to $34, says Eluvia and HeartLogic will be “real growth drivers for 2019”
Tigress recommends purchasing Boeing Co BA, says China’s airline expansion in domestic flights needs additional Boeing units; “I believe Boeing will trade above its all-time high of $371 in the next three to six months.”
Ladenburg Thalmann recommends acquiring shares of Tenax Therapeutics Inc TENX at current prices as firm believes the possible risk/reward of a positive phase 2 outcome could offer a strong risk/reward profile from current valuation; At time of publication, Tenax shares were trading up 12.6 percent.
Buckingham Research upgrades CarMax, Inc KMX from Neutral to Buy and trims price target from $77 to $75, sees 20 percent upside potential; “We believe comps and earnings growth will likely only improve from here."
JMP Securities upgrades Acuity Brands, Inc. AYI to Market Outperform and says stock is trading at “reasonable valuation”; “We are also encouraged that the company has reiterated its intention to continue returning capital to shareholders."